Magnet Biomedicine is a biotechnology company advancing molecular glue discovery with rational selection and design. We are reimagining what is achievable with molecular glues by looking beyond known protein–protein interactions and analyzing the broad protein landscape to pair target proteins with rationally selected presenter proteins to drive therapeutic effects. Our TrueGlue™ discovery platform applies cutting-edge advancements in human biology and proteomics to identify fit-for-purpose glues that offer category-leading benefits and maximize therapeutic impact.

Magnet Biomedicine

🔬 Exciting News from Magnet Biomedicine! 🌟 
 
👥 We're thrilled to announce that our leadership team will be attending the JP Morgan Healthcare Conference 2024! Our President & Chief Scientific Officer,  Brian Safina, Ph.D., along with Bret Williams, Ph.D., Vice President of Biology, and Diala Ezzeddine, Ph.D. from our corporate development team will be in attendance.    
 
Here's a sneak peek:

🤝 Strategic Partnerships & Relationships: At JP Morgan Healthcare Conference 2024, we're eager to explore new collaborations with established pharma players. Our focus is on building strong, mutually beneficial partnerships that can leverage our TrueGlue™ Discovery platform for groundbreaking advancements in precision medicine. 
 
🧬 Pipeline Progress: Witness the evolution of our TrueGlue™ Discovery platform, a testament to our commitment to innovation. We're excited to discuss how our platform is opening doors to new therapeutic possibilities, especially in addressing previously untreatable conditions. 
 
Join us in shaping the future of molecular glues in healthcare. The journey continues! 
 
Interested in connecting with us at the conference or via LinkedIn? Reach out to Diala Ezzeddine dezzeddine@magnetbio.com or visit our website at magnetbio.com.  
 
Let's innovate together! 
 
#JPM2024 #MagnetBiomedicine #HealthcareInnovation  

 

A new domain for the next chapter of our journey:  This week our team gathered to celebrate our new lab + office space in South End, Boston!

#Biotech #MolecularGlues

We had a great time chatting with Ryan Cross and Endpoints News about our Series A and the vast potential of molecular glues to address cancer, cardiovascular disease, immune disorders, and beyond 🧲

Check out the full article: https://lnkd.in/ejmS_Tqa


Thank you to our team and scientific founders, molecular glue pioneer Stuart Schreiber, 2017 Nobel Laureate Michael Rosbash, chemoproteomics pioneer Benjamin Cravatt, human geneticist Richa Saxena, and chemical biologist David Spiegel, for your commitment to advancing pioneering science with the potential to unlock new therapeutics.

#TrueGlues #MolecularGlues #Chemoproteomics #Biotech

Our TrueGlue™ discovery platform leverages next-generation technologies to identify TrueGlues, small molecules that offer category-leading benefits and opportunities to bring novel treatment options to patients.

Visit our website to learn more: magnetbio.com

#MolecularGlues #Biotech #DrugDiscovery

Today, Magnet Bio emerges from stealth with $50M in Series A financing. We’re building on the work of our scientific founders, advancing molecular glue discovery with rational selection and design to bring novel medicines to patients across a vast range of indications.     

Learn more at: https://magnetbio.com/

#MolecularGlues #Biotech #Startup

TRIANA Biomedicines is a competitor of Magnet Biomedicine specializing in biotechnology solutions for the healthcare sector.

TRIANA Biomedicines

Gotham Therapeutics competes with Magnet Biomedicine in the biotechnology sector, particularly in healthcare services.

Gotham Therapeutics

Seed Therapeutics is a competitor of Magnet Biomedicine, specializing in biotechnology solutions for healthcare services.

Seed Therapeutics

Metagenomi is a main competitor of Magnet Biomedicine, operating in the biotechnology sector with a focus on healthcare services.

Metagenomi

Chinook Therapeutics competes with Magnet Biomedicine in the biotechnology sector, particularly in healthcare services.

Chinook Therapeutics

Eleusis is a main competitor of Magnet Biomedicine, operating in the biotechnology sector with a focus on healthcare services.

Eleusis

leadXpro competes with Magnet Biomedicine in the biotechnology sector, particularly in healthcare services.

leadXpro

DNAnexus is a competitor of Magnet Biomedicine, specializing in biotechnology solutions for healthcare services.

DNAnexus

Eleven competes with Magnet Biomedicine in the biotechnology sector, particularly in healthcare services.

Eleven

Form Bio is a competitor of Magnet Biomedicine, specializing in biotechnology solutions for healthcare services.

Form Bio

Octant competes with Magnet Biomedicine in the biotechnology sector, particularly in healthcare services.

Octant

OneThree Biotech is a main competitor of Magnet Biomedicine, operating in the biotechnology sector with a focus on healthcare services.

OneThree Biotech

Lifebit competes with Magnet Biomedicine in the biotechnology sector, particularly in healthcare services.

Lifebit

Phenomic AI is a competitor of Magnet Biomedicine, specializing in biotechnology solutions for healthcare services.

Phenomic AI

Magnet Bio is a company that appears to specialize in biotechnology solutions. The exact nature of their products or services is not specified in the provided context, but their involvement in the healthcare sector is implied by their name and privacy policy page.

news impact assignment basic	general
public peers	general	May 16, 2024 7:22 AM	1a726b04
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 16, 2024 7:22 AM	d99c99a6
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:MAGNETBIO

Magnet Bio